European Pharmaceutical Review

MARCH 24, 2023

The European Medicines Agency (EMA) has published a report summarising the mid-point achievements of its Regulatory Science Strategy (RSS) to 2025. Regulatory science refers to the scientific disciplines that are applied to the quality, safety and efficacy assessment of medicinal products.

Medicine 96

Medicine Consulting Networking Safety 96

European Pharmaceutical Review

OCTOBER 22, 2024

The UK is set to be the first country to introduce a new regulatory framework for innovative products manufactured at or close to the point of patient care, says the Medicines and Healthcare products Regulatory Agency (MHRA). The agency anticipated that the regulation could become law in Summer 2025.

Medicine 89

Medicine Manufacturing Safety Consulting 89

European Pharmaceutical Review

AUGUST 30, 2023

The Windsor Framework, announced on 9 June 2023 by the Medicines and Healthcare products Regulatory Agency (MHRA), provides a long-term solution for the supply of medicines into Northern Ireland. The following new measures are set to be introduced on 1 January 2025.

Medicine 105

Medicine Marketing Government Safety 105

European Pharmaceutical Review

OCTOBER 17, 2024

In the UK, ARS Pharmaceuticals anticipates filing for approval from the Medicines and Healthcare products Regulatory Agency (MHRA) by Q4 2024, under their Mutual Recognition Process A, where MHRA will review and approve EURneffy based on the EMA approval within 60 days of filing. Motohiro E, Kento T, Kyohei T , et al.

Food and Drug Administration 121

Food and Drug Administration Medicine Consulting Food 121

European Pharmaceutical Review

JUNE 12, 2024

The main objective was to evaluate the efficacy and safety of MBK-01 compared to fidaxomicin, providing significant insights into the potential of MBK-01 as a treatment for primary or recurrent CDI and contributing to the advancement of microbiome-based therapies. The study included 92 adult patients with confirmed CDI.

Safety 111

Safety Patients Side effects Healthcare 111

Medico Reach

AUGUST 30, 2022

After all, healthcare is a sensitive topic for most people, especially racial and ethnic minorities. This adds to the existing obstacles in the healthcare related marketing efforts. Healthcare advertisements that feature patient experiences can evoke powerful emotions. Operating a medical business can be difficult.

Healthcare 52

Healthcare Healthcare Marketing Medical 52

pharmaphorum

DECEMBER 14, 2022

Tentative approval means Lumryz has satisfied all the FDA requirements for efficacy, safety, and quality standards, but it can’t be fully approved until a patent or other exclusivity expires. Jason Peterson RPh is a clinical pharmacist at RemedyOne, with over 25 years of experience in healthcare and pharmacy. Monopoly money.

Competition 116

Competition FDA Pharmaceutical Marketing 116

pharmaphorum

NOVEMBER 9, 2022

The present moment within and without healthcare, biotech, and pharma is a difficult and pivotal time in history, a time in which such issues need must be addressed. The keynote address of the event entire came from Stella Kyriakides, commissioner for health and food safety at the European Commission. Her opener?

Insurance 98

Insurance Patients Healthcare Healthcare 98

pharmaphorum

JANUARY 4, 2023

providing personalised healthcare consisting in assessing, maintaining, or restoring the state of health of individuals. The EC is hoping that, by the end of its current mandate on 31 October 2024, the legislative process will be completed, with the EHDS becoming operational in 2025.

Pharmaceutical 98

Pharmaceutical Electronics Healthcare Healthcare 98

pharmaphorum

SEPTEMBER 20, 2022

The phase 1/3 ROSALIA study showed that the copycat denosumab matched Amgen’s brand on multiple pharmacokinetics, pharmacodynamics, efficacy, safety, and immunogenicity measures in postmenopausal women with osteoporosis, said Sandoz in a statement.

Medicine 52

Medicine Marketing Safety Biopharma 52

Contrarian Sales Techniques

FEBRUARY 24, 2023

Key Initiatives for Public Healthcare, Education, And Infrastructure The Malaysian government just re-announced its Budget 2023 , highlighting various initiatives aimed at boosting the country's economy and providing support to its citizens. billion, with a focus on improving public healthcare, education, and infrastructure.

Government 52

Government Education Medical sales reps Food 52

Contrarian Sales Techniques

NOVEMBER 18, 2024

Let’s unpack the system that makes healthcare so accessible for Malaysians. On top of that, the Malaysian government subsidizes the cost to make healthcare accessible to everyone. In Budget 2025, the Ministry of Health received an allocation of RM45.3 billion for healthcare services, including subsidies for medications.

Government 52

Government Medicine Insurance Healthcare 52

Pharmaceutical Technology

MAY 25, 2023

The Medicines and Healthcare products Regulatory Agency (MHRA) aims to launch a pilot genetic biobank that will gather patient data to associate drug-related adverse events to their genetic makeup. According to the press release, the MHRA will be the first drug safety regulator in the world to pilot such a biobank.

Side effects 52

Side effects Medicine Recruitment Doctors 52

Clarivate

MAY 13, 2024

After staying relatively flat for several years, enrollment growth took off in 2021 after an expansion in federal subsidies for silver-level plans passed in the American Rescue Plan and was then renewed through 2025 in the Inflation Reduction Act. Pillo, Senior Healthcare Research and Data Analyst. The post The U.S.

Insurance 52

Insurance Marketing Healthcare Healthcare 52

Contrarian Sales Techniques

FEBRUARY 25, 2023

The pharmaceutical industry in India is growing rapidly and is expected to reach a value of US$100 billion by 2025, with a significant portion of that growth driven by domestic demand. One thing to note is that the market for generic drugs in Malaysia is growing, as more people are seeking affordable healthcare options.

Marketing 52

Marketing Distribution Medical Government 52

PM360

AUGUST 9, 2022

billion in 2025. One reason for this growth is an increasing demand for personalized healthcare technologies as patients look for advances in how healthcare is delivered following the pandemic. NovaXS is on a mission to simplify the medication self-administration process and improve remote healthcare adherence.

Prescription 105

Prescription Medical Patients Side effects 105

Scott Burrows

DECEMBER 13, 2024

Heres to embracing every opportunity, conquering every challenge, and making 2025 a year to remember. With a clear vision, a positive mindset, and unwavering grit, youre setting the stage for a year filled with growth, resilience, and extraordinary achievement. Dream big, work hard, and step boldly into the possibilities aheadyouve got this!

Management 52

Management Engineering Safety Insurance 52

European Pharmaceutical Review

FEBRUARY 7, 2023

From 31 January 2025, new and ongoing clinical trials in the EU must be conducted in compliance with the CTR. In addition, the devices must not present an unacceptable risk to patient and user health and safety as established in Articles 94 and 95 of the MDR. Authorisation of the clinical trial, may, however, be obtained later.

Medical 117

Medical Government Marketing Medicine 117

European Pharmaceutical Review

DECEMBER 19, 2023

Injection Safety Fact Sheet. Since vaccines can now be reformulated to meet the relevant WHO guidelines, the route to a future of fridge-free vaccines is open. Curr Med Chem. vander Straeten A, Sarmadi M, Daristotle JL, et al. A microneedle vaccine printer for thermostable COVID-19 mRNA vaccines. Nat Biotechnol. Internet] WHO. Internet] WHO.

Distribution 111

Distribution Manufacturing Food Pharmaceutical 111

Rep-Lite

JULY 27, 2023

billion by 2025. They serve as the primary link between healthcare providers and cutting-edge medical solutions. Adapting to the Changing Dynamics of Medical Device Sales Shifting Buyer Behavior in the Healthcare Industry As patients become more proactive in managing their health, buyer behavior in the healthcare industry evolves.

Sales 52

Sales Medical Medical sales Sales Strategy 52

Clarify Health

JULY 13, 2020

The panel included Bhash Parasuraman, PhD, Vice President and BU Lead, Rare Disease Patient & Health Impact, Pfizer , Calum MacRae, MD, PhD, Professor of Medicine at Harvard Medical School , and Surya Singh, MD, President, Singh Healthcare Advisors. By 2025, several new gene and cell therapies will be coming to market.

Pharmaceutical 52

Pharmaceutical Pharma Patients Marketing 52

Clarivate

OCTOBER 10, 2022

Fruquintinib was well-tolerated, with a safety profile consistent with that previously reported in other studies. The question of which KRAS inhibitor is most effective remains elusive, although being first to market in addition to strong efficacy and safety data could differentiate the more competitive agent. Market impact.

Marketing 52

Marketing Safety Patients Competition 52

Clarivate

AUGUST 27, 2024

In addition, the improved safety profile of PFA is making the cost-benefit of ablation an easier calculation for many patients. Still, analysts and providers project that Farapulse, which has more than 70% of the global market today, will continue to dominate at least through 2025. Abbott’s Volt should join the party in early 2026.

Marketing 52

Marketing Competition FDA Electronics 52

Pharmaceutical Technology

JULY 29, 2022

On 25 June, Pfizer and BioNTech (Mainz, Germany) reported pivotal Phase II/III data demonstrating the safety, tolerability and immunogenicity of two Omicron-adapted vaccine candidates. Jubilant will double its injectable filling capacity in Spokane at a cost of $193m, to be completed by 2025. 1 sub-lineage on 19 July.

Manufacturing 52

Manufacturing Food and Drug Administration Marketing FDA 52

Pharmaceutical Technology

DECEMBER 21, 2022

This could spell high-stake consequences for consumers whose privacy and safety could be at risk if AI models are not regulated. According to GlobalData, global AI revenues in the pharmaceutical, medical, and healthcare sectors are expected to reach almost $21 billion by 2025.

Pharma 140

Pharma Pharmaceutical Medicine Government 140

Pharmaceutical Technology

FEBRUARY 23, 2023

It is a health movement that prioritizes superhuman health for those who can afford it, instead of providing greater equitable access to healthcare for all. billion by 2025. While preventative healthcare and personal responsibility can be valuable, in the case of biohacking and its unverified methods, there can be dangerous outcomes.

Media 111

Media Healthcare Healthcare Ethics 111